The story of Viagra, formerly marketed by copyright, presents a intricate case study for backers considering the pharmaceutical landscape . While its groundbreaking success and generation of billions in sales, the exclusivity expiration has opened the floodgates for alternative medications, greatly diminishing earnings prospects . This shift raises